Glac Biotech Co., Ltd.

Yen-Yu Huang

Hsieh-Hsun Ho

Yi-Wei Kuo

Wen-Yang Lin

Jia-Hung Lin

Ching-Wei Chen

Chi-Huei Lin

Shin-Yu Tsai

Ko-Chiang Hsia

Yu-Fen Huang

Shu-Hui Chen

Hui-Shan Wang

Cheng-Ruei Liu

Disclosed herein is a probiotic composition includingsubsp.AP-32 that is deposited at the China Center for Type Culture Collection (CCTCC) under an accession number CCTCC M 2011127, andsubsp.OLP-01 that is deposited at the China General Microbiological Culture Collection Center (CGMCC) under an accession number CGMCC 17345. Also disclosed herein are use of at least one of the abovementioned lactic acid bacterial strains for treating obesity and/or an obesity-related disorder, and for inhibiting fat absorption.

Probiotic composition including lactic acid bacterial strains and use of at least one of such strains

The present invention discloses an anti-aging composition, which includes: (a) isolated lactic acid bacterial strains or a fermented product thereof; and (b) an excipient, a diluent, or a carrier; wherein the isolated lactic acid bacterial strains include:VDD088 strains,Bv-889 strains, andBLI-02 strains. The present invention further provides a method for preventing aging by administering the foregoing anti-aging composition to a subject in need thereof.

Anti-aging composition and use thereof for preventing aging

Disclosed herein is a probiotic composition that includessubsp.AP-32,MH-68, andsubsp.CP-9, which are deposited at the China Center for Type Culture Collection (CCTCC) respectively under accession numbers CCTCC M 2011127, CCTCC M 2011128, and CCTCC M 2014588. A number ratio ofsubsp.AP-32,MH-68, andsubsp.CP-9 ranges from 1:0.1:0.1 to 1:1:8. Also disclosed herein is use of the probiotic composition for alleviating type 1 diabetes mellitus (T1DM).

Probiotic composition including lactic acid bacterial strains and use thereof

Disclosed herein is a method for alleviating atopic dermatitis using a composition containing at least one lactic acid bacterial strain. The at least one lactic acid bacterial strain is selected from the group consisting ofsubsp.AP-32 which is deposited at the China Center for Type Culture Collection (CCTCC) under an accession number CCTCC M 2011127, andsubsp.CP-9 which is deposited at the CCTCC under an accession number CCTCC M 2014588.

Method for alleviating atopic dermatitis

The invention provides a method of increasing an amount of oral immunoglobulin A (IgA) and/or inhibiting oral pathogens in a subject in need thereof, which utilizes a composition including a therapeutically effective amount of probiotics as an effective ingredient. The probiotics includeLPL28, which can efficiently increase the amount of oral IgA and/or inhibit the oral pathogens, and thus have a potential to prevent teeth cavities and/or periodontal diseases.

Composition including probiotics and method of increasing amount of oral immunoglobulin A and inhibiting oral pathogens by administering the same

The present invention provides a lactic acid bacterial composition for inhibiting the activity ofand/or treating or preventing jaundice, the composition including: asubsp.CP-9 strain and asubsp.AP-32 strain. The present invention further provides a method for inhibiting growth of, the method including the step(s) of: administering the foregoing lactic acid bacterial composition to a subject in need thereof. The present invention additionally provides a method for treating or preventing jaundice, the method including the step(s) of: administering the foregoing lactic acid bacterial composition to a subject in need thereof.

Growing community of inventors

Tainan, Taiwan

Yen-Yu Huang